Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancer

Published:2013-04 Issue:1 Volume:80 Page:62-67
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Wiersma Terry G.,Dahele Max,Verbakel Wilko F.A.R.,van de Ven Peter M.,de Haan Patricia F.,Smit Egbert F.,van Reij Ellen J.F.,Slotman Ben J.,Senan Suresh

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference15 articles.

1. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Auperin;J Clin Oncol,2010

2. Concurrent chemoradiotherapy in non-small cell lung cancer;O’Rourke;Cochrane Database Syst Rev,2010

3. Dutch statistics on lung cancer: sobering experience for a new approach;Zwitter;J Thorac Oncol,2012

4. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma;Bradley;Int J Radiat Oncol Biol Phys,2002

5. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer;Furuse;J Clin Oncol,1999

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis;Strahlentherapie und Onkologie;2023-11-17

2. Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis;eClinicalMedicine;2023-10

3. Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition;European Journal of Nuclear Medicine and Molecular Imaging;2021-10-19

4. Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition;Investigational New Drugs;2021-08-05

5. Clinical Impact of Supraclavicular Lymph Node Involvement of Stage IIIC Non-Small Cell Lung Cancer Patients;Medicina;2021-03-23